Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
出版年份 2018 全文链接
标题
Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
作者
关键词
Multiple sclerosis, Alemtuzumab, Autoimmune thyroid disease, Immune reconstitution, Algorithm, Management
出版物
ACTA NEUROLOGICA BELGICA
Volume 118, Issue 2, Pages 153-159
出版商
Springer Nature
发表日期
2018-01-25
DOI
10.1007/s13760-018-0883-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
- (2017) Erik K. Alexander et al. THYROID
- Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
- (2017) David Baker et al. JAMA Neurology
- Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response
- (2017) Mario Rotondi et al. Frontiers in Endocrinology
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
- (2016) Douglas S. Ross et al. THYROID
- Autoimmune thyroid disorders
- (2015) Alessandro Antonelli et al. AUTOIMMUNITY REVIEWS
- Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
- (2015) Moeber Mahzari et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond
- (2015) Tobias Ruck et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Graves' disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?
- (2014) Anthony P. Weetman CLINICAL ENDOCRINOLOGY
- A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis
- (2013) Gilbert H. Daniels et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
- (2012) Jeffrey R. Garber et al. THYROID
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- The role of thyroid autoimmunity in fertility and pregnancy
- (2008) Kris Poppe et al. Nature clinical practice. Endocrinology & metabolism
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started